NEW YORK, April 15 /PRNewswire/ -- WallSt.net's 3-Minute Press Show is a daily video program hosted by WallSt.net reporter, Tracee Tolentino.
Shows air Monday through Friday on:
WallSt.net's 3-Minute Press Show features in-depth interviews with public company executives on their company and most recent press releases. The show is designed to provide viewers with insight into a company's most recent press release, and its impact on the company's growth.
About WallStreet Direct, Inc.
WallStreet Direct, Inc. a wholly-owned subsidiary of Financial Media Group, Inc., owns and operates WallSt.net (http://www.wallst.net), a leading source of up-to-the-minute business news, comprehensive financial tools and original multimedia content for the investment community. In addition to WallSt.net, WallStreet Direct owns and operates WallStRadio (http://radio.wallst.net) an online hub for business podcasts from well-known business news personalities and publishers. We have received ten thousand dollars from Nutra Pharma Corp. for media and advertising services. We have received ten thousand dollars, and twenty thousand free trading shares of PECD from a third party for media and advertising services for Pet Ecology Brands, Inc. We have received four hundred ninety five dollars from Pinnacle Resources, Inc. for the dissemination of this press release. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.php.
About Nutra Pharma Corp.
Nutra Pharma Corp. is a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases. Nutra Pharma Corp. through its subsidiaries carries out basic drug discovery research and clinical development and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process. The Company's subsidiary, ReceptoPharm, Inc., is developing these technologies for the production of drugs for HIV and Multiple Sclerosis ("MS"). The Company's subsidiary, Designer Diagnostics, is engaged in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious diseases such as Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI). Nutra Pharma continues to identify and acquire intellectual property and companies in the biotechnology arena.
About Pet Ecology Brands, Inc.
Pet Ecology Brands, Inc. has developed a revolutionary patented cat litter that destroys urine odor, clumps, and is earth-friendly. The litter is ultra-lightweight and convenient to use (3 lbs works like 21 lbs of clay/ sand-based products), it is 100% flushable and safe for sewer and septic tank systems. Most importantly, it is completely safe for cats and our environment, and does not contain any sodium bentonite, as used in many competing brands. The design helps to protect the landfills, and yet does everything that clay litters do... and more. It has the ability to help indicate certain diseases commonly occurring in cats. The technique used is similar to that found in Merck's Veterinarian Manual. However, this litter not only warns of possible illness, but may also help indicate how far along the illness may be by the color the litter changes to, thereby providing the pet owner significant additional benefits and an early warning system concerning the cat's health.
About Pinnacle Resources, Inc.
Pinnacle Resources, Inc. engages in the exploration and development of natural resources. It engages in mining ocean diamonds, refining tantalum, and developing its vanadium/titanium property in South Africa. The company, through its interest in Orovi Ghana, Ltd., holds a gold prospecting right on the Riyadh concession in the central district of the Republic of Ghana.
SOURCE WallStreet Direct, Inc.; Nutra Pharma Corp.; Pet Ecology Brands Inc.; Pinnacle Resources, Inc.